Press Releases

 Filter by Provider

De Krupe Law, a seven-time award-winning real estate law firm in Toronto, is sounding the alarm on Ontario’s rapidly decelerating real estate market, citing a sharp decline in transactions across the Greater Toronto Area. Founder and lead expert Stanislav Aranush de Krupe, recognized consecutively as one of the "Top 3 Real Estate Lawyers in Newmarket," points to rising tariffs, financing instability, and tightening buyer confidence as key drivers of the slowdown.

Tampa, Florida () June 13, 2025 -- New flashcard platform combines traditional study methods with cutting-edge adaptive learning algorithms to maximize memory retention for physical therapy students

TORONTO, ON / ACCESS Newswire / June 13, 2025 / Highlander Silver Corp. (TSX:HSLV) ("Highlander Silver" or the "Company") is pleased to announce that all matters presented for approval at the Company's annual meeting of shareholders held yesterday, as more particularly set out in the Company's Management Information Circular dated April 29, 2025, have been approved. These matters included:

Deal adds immediate Northeast, Mid-Atlantic and Midwest scale and accelerates rollout of innovative products like Rhythm's PowerShift Time-of-Use plan

Unlocking New Wellness Markets with Precision Messaging and Storytelling Strategy for Growth

BURLINGTON, ON / ACCESS Newswire / June 13, 2025 / Safe 'N' Sound Environmental Services Ltd., a Burlington-based environmental remediation firm, has been recognized with the 2025 Consumer Choice Award in the Asbestos Removal category in the Halton Region. This distinction highlights the company's commitment to providing safe, effective, and fully certified environmental solutions for both residential and commercial clients.

Citizens Financial Group, Inc. (NYSE: CFG or the “Company”) today announces that its board of directors has increased the capacity of the Company’s common share repurchase program to $1.5 billion, an increase of $1.2 billion above the $300 million of capacity currently remaining under the prior June 2024 authorization.

Berkshire Hathaway HomeServices California Properties proudly announces that Phil Missig has been awarded the elite Sports and Entertainment Certification, a distinction reserved exclusively for agents within the Berkshire Hathaway HomeServices global Luxury Collection.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced new data from its preclinical study of ZL-1503, the Company’s promising IL-13/IL-31R bispecific antibody, demonstrating its ability to simultaneously suppress the inflammatory and pruritogenic (itch-causing) pathways in atopic dermatitis (AD). The findings, featured during a poster presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, Scotland, highlight the potential of ZL-1503 as a novel treatment option for moderate-to-severe AD.

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced positive initial results from the target enrollment group in the ongoing ALPHA-SOLAR long-term open-label trial evaluating navenibart (STAR-0215), a monoclonal antibody inhibitor of plasma kallikrein, in hereditary angioedema (HAE) patients. These results demonstrated robust overall reduction in the monthly attack rate (92% mean and 97% median). These results further support navenibart’s favorable safety and tolerability profile, and potential every three- (Q3M) and every six-month (Q6M) dosing regimens.

Quinbrook Infrastructure Partners (“Quinbrook”), a specialist global investment manager focused exclusively on the infrastructure needed for the energy transition, today announced several moves to strengthen its executive leadership and support ongoing growth.

LAIKA’s award-winning stop-motion animated film ParaNorman returns this Halloween for a one-week theatrical engagement.

BURLINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today announced it will present a poster of new preclinical data from its Rejuva Smart GLP-1 pancreatic gene therapy platform at the American Diabetes Association’s (ADA) 85th Scientific Sessions being held June 20-23, 2025, in Chicago, Illinois.

Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and Resolution of Anemia

HOUSTON and LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR) will announce the results of the second quarter ending June 30, 2025, via press release at 5 p.m. Eastern Time (4 p.m. Central Time) on Tuesday, July 22, 2025. A webcast to discuss the results will be held Wednesday, July 23, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time).

SINGAPORE , June 13, 2025 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a leading personal finance aggregation and comparison platform, as well as a digital insurance brokerage provider in Greater Southeast Asia, today announced its financial results for the first quarter ended March 31, 2025.

TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce its intention to declare a special dividend consisting of Contingent Value Rights (the “CVRs”) to be issued on a 1:1 basis to holders of the Company’s Class B Subordinate Voting Shares.

DENVER, CO / ACCESS Newswire / June 13, 2025 / The Boards of Trustees (the "Boards") of the following closed-end funds (the "Funds") advised by Clough Capital Partners L.P. (the "Adviser" or "Clough Capital") announced that each Fund has renewed its share repurchase program under which it may purchase up to 5% of its outstanding common shares in open market transactions through June 30, 2026:

Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR), the first and only real estate company on the New York Stock Exchange focused on the regulated U.S. cannabis industry, announced today that its board of directors has declared a second quarter 2025 dividend of $1.90 per share of common stock, representing an annualized dividend of $7.60 per common share. Since its inception in 2016, IIP has paid over $940 million in common stock dividends to its shareholders.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, for the treatment of adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors express PD-L1 (Combined Positive Score [CPS] ≥1) as determined by an FDA-approved test, as a single agent as neoadjuvant treatment, continued as adjuvant treatment in combination with radiotherapy (RT) with or without cisplatin and then as a single agent.

Booz Allen Hamilton Holding Corporation (NYSE: BAH), the parent company of advanced technology company Booz Allen Hamilton Inc., will host a conference call at 8 a.m. EDT on Friday, July 25, 2025, to discuss the financial results for the First Quarter of Fiscal 2026 (ending June 30, 2025). A news release containing the results will be issued before the call.

Invitation Homes Inc. (NYSE: INVH) (“Invitation Homes” or the “Company”), the nation’s premier single-family home leasing and management company, announced today that it has declared a quarterly cash dividend of $0.29 per share payable on shares of its common stock. The dividend will be paid on or before July 18, 2025, to stockholders of record of the Company’s common stock as of the close of business on June 26, 2025.

New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib

In Baku, the average speed has risen from 18 to 22 km/h, reducing travel times by up to 22 minutes on some routes. With around 900,000 passengers using buses daily, this marks a significant improvement in both efficiency and convenience.

Vancouver, British Columbia / June 13, 2025 ‑ TheNewswire - Harvest Gold Corporation (TSXV: HVG) (“ Harvest Gold ” or the “ Company ”) is pleased to announce the results of its annual general meeting (the “AGM”) held on June 12, 2025. All resolutions presented to the shareholders were approved with over 99% of votes cast being in favour of each resolution.

Apogee Enterprises, Inc. (Nasdaq: APOG), a leading provider of architectural building products and services, as well as high-performance coated materials used in a variety of applications, today announced that the company will report its fiscal 2026 first quarter results on Friday, June 27, 2025, before the market opens. Apogee’s management team will host a conference call to discuss the financial results and to provide a business update. The conference call will begin on June 27 at 8:00 a.m. Central Time.

Agents and teams from Berkshire Hathaway HomeServices California Properties have once again been acknowledged among the nation’s best, as designated in this year’s prestigious REALTrends Verified The Thousand, an annual awards ranking sponsored by REALTrends.

Highlights:

Singapore, June 13, 2025 (GLOBE NEWSWIRE) -- Springview Holdings Ltd (Nasdaq: SPHL) (“Springview Holdings”, or the “Company”), a leading designer and builder of residential and commercial properties in Singapore, today announced that its indirect wholly owned Singapore operating subsidiary, Springview Enterprises Pte. Ltd. (“Springview Singapore”) has been officially awarded bizSAFE Level 4 certification by the Workplace Safety and Health Council, effective June 9, 2025. This milestone marks a major leap forward in Springview Singapore’s journey toward operational excellence and sustainable growth.

In the ever-changing global financial market, Benedikt Bergmann stands out with his exceptional expertise and leadership, guiding Eisberg Capital Partners to new heights in innovative and sustainable investment management. As a Senior Investment Manager and Head of the Analyst Team at this renowned company, the 55-year-old Mr. Bergmann has earned widespread trust from high-net-worth clients, institutional investors, and colleagues, thanks to his over 20 years of asset management experience, decisive decision-making ability, and client-centered approach. His key role at Eisberg Capital Partners highlights the company's reputation as a global leader in systematic, transparent, and high-impact investment solutions.

As the global economy enters a new phase of digitalization and sustainability, the demand from investors for high-growth opportunities and stable returns is increasing. The rise of emerging technologies such as artificial intelligence, blockchain, and clean energy is reshaping the global market landscape, while the complexity of geopolitical and economic fluctuations is placing greater demands on investment strategies. In this financial environment full of both opportunities and challenges, innovation and expertise have become the key to success. Eisberg Capital Partners, a leading investment management firm based in the United States with operations in over 20 countries, continues to redefine the possibilities of wealth creation for global investors with its forward-thinking strategies and exceptional performance. Following its outstanding results in the second quarter of 2025, which far exceeded expectations, the company is proud to announce the launch of its "Third Quarter Smart Wealth Creation Program," backed by a €1.5 billion dedicated reward fund. The initiative aims to build a stable, high-growth wealth engine for both new and existing members. This move not only demonstrates the company’s strategic ambition but also reflects its deep commitment to the trust of its investors, striving to create a new chapter in wealth management on the global financial stage.

CINCINNATI, OHIO / ACCESS Newswire / June 13, 2025 / Nerdaxe Hydro, a developer of precision liquid-cooled mining hardware, has announced the upcoming release of the NerdQaxe+ Hydro - its first liquid-cooled version of the open-source NerdQaxe+ Bitcoin miner. Launching June 23, this marks a new milestone in solo mining innovation and hardware design.

Curiosity Inc. (Nasdaq: CURI), a global factual media and entertainment company, today announced a new slate of international content licensing agreements, reinforcing its strategic focus on distribution and global audience reach. These partnerships span linear broadcasters, educational platforms, and digital outlets across multiple continents, solidifying Curiosity’s role as a leading global supplier of premium factual storytelling.

Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced a strategic collaboration with Thermo Fisher Scientific, the world leader in serving science, to provide a fully integrated mRNA solution to biopharmaceutical developers.

Cloudflare, Inc. (“Cloudflare”) (NYSE: NET) today announced the pricing of $1.75 billion aggregate principal amount of Convertible Senior Notes due 2030 (the “notes”) in a private offering (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act of 1933, as amended (the “Securities Act”). Cloudflare also granted the initial purchasers of the notes a 13-day option to purchase up to an additional $250 million aggregate principal amount of the notes solely to cover over-allotments. The sale of the notes to the initial purchasers is expected to settle on June 17, 2025, subject to customary closing conditions, and is expected to result in approximately $1.72 billion in net proceeds to Cloudflare after deducting the initial purchasers’ discount and estimated offering expenses payable by Cloudflare (assuming no exercise of the initial purchasers’ option to purchase additional notes).

Global real estate investment company Kennedy Wilson has partnered with Kenedix, Inc. and Hulic Co., Ltd. to acquire The Danforth in Seattle for $173 million. The 265-unit multifamily community with Whole Foods as the sole ground-floor tenant builds on Kennedy Wilson’s significant multifamily presence in the Pacific Northwest that totals more than 13,000 market rate and affordable apartment units.

Nichole Story of Berkshire Hathaway HomeServices California Properties recently helped one of her seller clients realize a substantial return on investment through her interior design, staging and refreshment services. After evaluating the property condition, architecture and neighborhood, Story implemented a comprehensive six-week reimagining process for the home, which is located at 517 Poppy Avenue in Newport Beach and closed for $3.1 million.

Hong Kong, China--(Newsfile Corp. - June 13, 2025) - The 2025 International Automotive Supply Chain Expo (Hong Kong), co-hosted by...

Regulatory News:

O’Neill Vintners & Distillers, a Certified B Corp company, has appointed Breakthru Beverage Group as its new distribution partner in California, effective August 1, 2025. The decision follows the exit of Republic National Distributing Company from the California market and represents a strategic move to ensure continuity, service excellence, and long-term alignment in one of the country’s most important wine markets.

SHANGHAI, CHINA - Media OutReach Newswire - 13 June 2025 - The second season of Our Water: Flowing from Shanghai – Intercultural Dialogues Among World...

BRITISH VIRGIN ISLANDS / ACCESS Newswire / June 13, 2025 / ANGL Inc., parent company of the utility asset $ANGL, confirmed that its token generation event will take place on June 18, 2025, with initial liquidity provided on Uniswap. $ANGL is the utility token that powers AI-driven engagement, automation, and financial inclusion across the Angel Twin ecosystem, giving individuals a direct financial stake in the services which their AI "twins" perform.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, co-led the first study to demonstrate that characterizing genetic material near chromosomes forecasts how mutated, cancer-causing genes reengineer DNA and alter the tumor microenvironment. The leading-edge brain cancer research provides foundational knowledge that one day will improve the practice of precision medicine and allow oncologists to deliver more personalized therapies to cancer patients.

Appointment Underscores RetinalGenix’s Commitment to Integrating the Latest Advances in Genomics and Personalized Medicine into its Product Pipeline

Knaresborough, United Kingdom--(Newsfile Corp. - June 13, 2025) - Garden Furniture, a trusted name in British outdoor living for over...

Garching / Munich, Germany, June 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will provide further analysis from its recently completed Phase 3 COMPETE trial in an oral presentation and Satellite Symposium at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, held from June 21 – June 24, 2025 in New Orleans, Louisiana. Details of the Oral PresentationThe data will be presented by Dr. Thomas A. Hope, MD, Chief of Nuclear Medicine at the San Francisco VA Medical Center and Vice Chair of Clinical Operations and Strategy in the Department of Radiology at UCSF in an oral presentation titled, “Predicting the [177Lu]Lu-edotreotide uptake in tumors using pre-therapeutic Ga-68 PET/CT imaging”, on Sunday, June 22 in the Neuroendocrine - Oncology Clinical Diagnosis and Therapy session from 3:30 – 4:45 pm CDT. The presentation will provide an analysis on the 177Lu-edotreotide tumor uptake and its predictability based on pre-therapeutic SSTR PET/CT imaging and other factors.